Top Markets
Coin of the day
Odyssey Therapeutics, Inc. Odyssey Therapeutics, Inc.

Odyssey Therapeutics, Inc.

ODTX
Hisse Senetlerindeki Sıralama #8753
Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused... Odyssey Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on discovering and developing novel treatments for autoimmune and inflammatory diseases. Its diverse pipeline features several key drug candidates: OD-001, an oral small molecule that inhibits receptor-interacting protein kinase 2, which is currently in Phase 2a clinical trials for ulcerative colitis. Also included is OD-002, an oral small molecule SLC15A4 inhibitor engineered to prevent harmful inflammatory responses driven by TLR7/8/9-mediated activation of interferon regulatory factor 5 (IRF5). Another program, OD-003, is a protein therapeutic designed to selectively agonize tumor necrosis factor receptor 2 on T regulatory cells. Further assets in its portfolio comprise a bispecific antagonist targeting TSLP and IL-33, an oral small molecule functioning as an interleukin-1 receptor-associated kinase 4 scaffolding inhibitor, and a separate small molecule inhibitor specifically targeting IRF5. The company was founded in 2021 and is headquartered in Boston, Massachusetts.
Hisse Fiyatı
$24.55
Son senkronizasyon: 2026-08-28
Piyasa Değeri
$1.18B
Değişim (1 gün)
-5.50%
Değişim (1 yıl)
-
Ülke
US
Ticaret Odyssey Therapeutics, Inc. (ODTX)

Kategori

Odyssey Therapeutics, Inc. (ODTX) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $23.17 - 2026-08-01

Gün sonu en düşük fiyat: $17.39 - 2026-05-01
Odyssey Therapeutics, Inc. için hisse fiyatı geçmişi: 2026 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH